An update: circulating tumor cells in head and neck cancer-Reference-Cited by-同舟云学术

An update: circulating tumor cells in head and neck cancer

Published:2019-11-07 Issue:12 Volume:19 Page:1109-1115
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Kulasinghe Arutha¹²,Hughes Brett G.M.³⁴,Kenny Liz³⁴⁵,Punyadeera Chamindie¹²

Affiliation:

1. Saliva and Liquid Biopsy Translational Research Team, The School of Biomedical, Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Queensland, Australia

2. Translational Research Institute, Brisbane, Australia

3. Cancer Care Services, Royal Brisbane and Women’s Hospital, Herston, Queensland, Australia

4. University of Queensland, Australia

5. Queensland Health, Central Integrated Regional Cancer Services

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737159.2020.1688145

Reference76 articles.

1. Current trends in the etiology and diagnosis of HPV ‐related head and neck cancers

2. Circulating tumour cells in metastatic head and neck cancers

3. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

4. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

5. Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma patients;Cellular and Molecular Life Sciences;2024-05-23

2. Extracellular vesicle‐based biomarker in head and neck cancer: prospects and challenges;Malignancy Spectrum;2024-04-06

3. Magnetically-activated, nanostructured cellulose for efficient capture of circulating tumor cells from the blood sample of head and neck cancer patients;Carbohydrate Polymers;2024-01

4. Exploring the Role of Circulating Tumor Cells in Contralateral Neck Metastasis;Journal of Head & Neck Physicians and Surgeons;2024-01

5. Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics (Review);Oncology Reports;2023-10-20